Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

European Journal of Neuroscience

Volumn 22, Issue 2, 2005, Pages 371-379

  Sagar, Devi Rani ^a   Kelly, Sara ^c   Millns, Paul J ^a   O'Shaughnessey, Celestine T ^b   Kendall, David A ^a   Chapman, Victoria ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cannabinoid receptor; Dorsal root ganglia; Electrophysiology; Neuropathic pain; Spinal dorsal horn neurons

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; ARACHIDONYL 2 CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; RIMONABANT; UNCLASSIFIED DRUG; 1,1 DIMETHYLBUTYL 1 DEOXY DELTA(9) THC; 1,1-DIMETHYLBUTYL-1-DEOXY-DELTA(9)-THC; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; BORNANE DERIVATIVE; CALCIUM; CANNABINOID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SPINAL CORD NERVE CELL; SPINAL GANGLION; ACTION POTENTIAL; ANIMAL; ANIMAL BEHAVIOR; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; EVOKED RESPONSE; HYPERALGESIA; LIGATION; METABOLISM; METHODOLOGY; NERVE CELL; NERVE CELL INHIBITION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; SPINAL CORD DISEASE; SPRAGUE DAWLEY RAT; TOUCH;

ACTION POTENTIALS; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BORNANES; CALCIUM; CANNABINOIDS; CAPSAICIN; CELLS, CULTURED; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EVOKED POTENTIALS; GANGLIA, SPINAL; HYPERALGESIA; LIGATION; MALE; NEURAL INHIBITION; NEURONS; PAIN MEASUREMENT; PIPERIDINES; POSTERIOR HORN CELLS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPINAL CORD DISEASES; TOUCH;

EID: 23244444097     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04206.x     Document Type: Article

References (54)

1. Ahluwalia, J., Urban, L., Bevan, S., Capogna, M. & Nagy, I. (2002) Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience, 110, 747-753.
2. Ahluwalia, J., Urban, L., Capogna, M., Bevan, S. & Nagy, I. (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688.
3. Andrew, D. & Greenspan, J.D. (1999) Peripheral coding of tonic mechanical cutaneous pain: comparison of nociceptor activity in rat and human psychophysics. J. Neurophysiol., 82, 2641-2648.
4. Bridges, D., Ahmad, K. & Rice, A.S. (2001) The synthetic Cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br. J. Pharmacol., 133, 586-594.
5. Bridges, D., Rice, A.S., Egertova, M., Elphick, M.R., Winter, J. & Michael, G.J. (2003) Localisation of Cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience, 119, 803-812.
6. Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature, 394, 277-281.
7. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. & Yaksh, T.L. (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Meth., 53, 55-63.
8. Chapman, V. (2001) Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats. Neuropharmacology, 41, 870-877.
9. Chapman, V., Suzuki, R. & Dickenson, A.H. (1998) Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. J. Physiol. (Lond.), 507, 881-894.
10. Colburn, R. W., Rickman, A.J. & DeLeo, J. A. (1999) The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol, 157, 289-304.
11. De Vry, J., Kuhl, E., Franken-Kunkel, P. & Eckel, G. (2004) Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur. J. Pharmacol., 491, 137-148.
12. Drew, L.J., Harris, J., Millns, P.J., Kendall, D.A. & Chapman, V. (2000) Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. Eur. J. Neurosci., 12, 2079-2086.
13. Elmes, S.J., Jhaveri, M.D., Smart, D., Kendall, D.A. & Chapman, V. (2004) Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur. J. Neurosci., 20, 2311-2320.
14. Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L. & James, I. (2001) The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
15. Garrison, C.J., Dougherty, P.M. & Carlton, S.M. (1994) GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp. Neurol., 129, 237-243.
16. Herzberg, U., Eliav, E., Bennett, G.J. & Kopin, I.J. (1997) The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett., 221, 157-160.
17. Hillard, C.J., Manna, S., Greenberg, M.J., DiCamelli, R., Ross, R.A., Stevenson, L.A., Murphy, V., Pertwee, R.G. & Campbell, W.B. (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther., 289, 1427-1433.
18. Hohmann, A.G. & Herkenham, M. (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 90, 923-931.
19. Hohmann, A.G., Tsou, K. & Walker, J.M. (1998) Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci. Lett., 257, 119-122.
20. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R. & Pertwee, R.G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
21. Hudson, L.J., Bevan, S., Wotherspoon, G., Gentry, C., Fox, A. & Winter, J. (2001) VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci., 13, 2105-2114.
22. 2 receptor. Bioorg. Med. Chem., 7, 2905-2914.
23. Ibrahim, M.M., Deng, H., Zvonok, A., Cockayne, D.A., Kwan, J., Mata, H.P., Vanderah, T.W., Lai, J., Porreca, F., Makriyannis, A. & Malan, T.P. Jr (2003) Activation of CB2 cannabinoid receptors by AM 1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl Acad. Sci. USA, 100, 10529-10533.
24. Jensen, T.S., Gottrup, H., Sindrup, S.H. & Bach, F.W. (2001) The clinical picture of neuropathic pain. Eur. J. Pharmacol., 429, 1-11.
25. Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L. & Schneider, U. (2003) Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. Jama, 290, 1757-1762.
26. Kelly, S. & Chapman, V. (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J. Neurophysiol., 86, 3061-3064.
27. Kelly, S. & Chapman, V. (2003) Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation. Eur. J. Pharmacol., 474, 209-216.
28. Kelly, S., Jhaveri, M.D., Sagar, D.R., Kendall, D.A. & Chapman, V. (2003) Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. Eur. J. Neurosci., 18, 2239-2243.
29. Khasabova, I.A., Simone, D.A. & Seybold, V.S. (2002) Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience, 115, 613-625.
30. Kim, S.H. & Chung, J.M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355-363.
31. Klegeris, A., Bissonnette, C.J. & McGeer, P.L. (2003) Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br. J. Pharmacol., 139, 775-786.
32. Kumar, R.N., Chambers, W.A. & Pertwee, R.G. (2001) Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia, 56, 1059-1068.
33. Lindsay, R.M. (1988) Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci., 8, 2394-2405.
34. Malan, T.P. Jr, Ibrahim, M.M., Deng, H., Liu, Q., Mata, H.P., Vanderah, T., Porreca, F. & Makriyannis, A. (2001) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain, 93, 239-245.
35. Malan, T.P. Jr, Ibrahim, M.M., Lai, J., Vanderah, T.W., Makriyannis, A. & Porreca, F. (2003) CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr. Opin. Pharmacol., 3, 62-67.
36. Mao, J., Price, D.D., Lu, J., Keniston, L. & Mayer, D.J. (2000) Two distinctive antinociceptive systems in rats with pathological pain. Neurosci. Lett., 280, 13-16.
37. Merrill, E.G. & Ainsworth, A. (1972) Glass-coated platinum-plated tungsten microelectrodes. Med. Biol. Eng., 10, 662-672.
38. Millns, P.J., Chapman, V. & Kendall, D.A. (2001) Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br. J. Pharmacol., 132, 969-971.
39. Molina-Holgado, E., Vela, J.M., Arevalo-Martin, A., Almazan, G., Molina-Holgado, F., Borrell, J. & Guaza, C. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J. Neurosci., 22, 9742-9753.
40. Patel, H.J., Birrell, M.A., Crispino, N., Hele, D.J., Venkatesan, P., Barnes, P.J., Yacoub, M.H. & Belvisi, M.G. (2003) Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br. J. Pharmacol., 140, 261-268.
41. Pertwee, R.G. (2001) Cannabinoid receptors and pain. Prog. Neurobiol., 63, 569-611.
42. Raghavendra, V., Tanga, F. & DeLeo, J.A. (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther., 306, 624-630.
43. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D. et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
44. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Breliere, J.C. & Le Fur, G.L. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
45. Ross, R.A., Coutts, A.A., McFarlane, S.M., Anavi-Goffer, S., Irving, A.J., Pertwee, R.G., MacEwan, D.J. & Scott, R.H. (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology, 40, 221-232.
46. 1 receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat. Eur. J. Neurosci., 20, 175-184.
47. Scott, D.A., Wright, C.E. & Angus, J.A. (2004) Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain, 109, 124-131.
48. Sheen, K. & Chung, J.M. (1993) Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model. Brain Res., 610, 62-68.
49. Shir, Y. & Seltzer, Z. (1990) A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci. Lett., 115, 62-67.
50. Suzuki, R., Kontinen, V.K., Matthews, E., Williams, E. & Dickenson, A.H. (2000) Enlargement of the receptive field size to low intensity mechanical stimulation in the rat spinal nerve ligation model of neuropathy. Exp. Neurol, 163, 408-413.
51. Wade, D.T., Robson, P., House, H., Makela, P. & Aram, J. (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin. Rehabil, 17, 21-29.
52. Yoon, Y.W., Na, H.S. & Chung, J.M. (1996) Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain, 64, 27-36.
53. Zhang, J., Hoffert, C., Vu, H.K., Groblewski, T., Ahmad, S. & O'Donnell, D. (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J. Neurosci., 17, 2750-2754.
54. Zimmermann, M. (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.